Versant Capital Management »

Marker Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Marker Therapeutics (MRKR) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Marker Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Marker Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marker Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $64 15 4.33
2023-12-31 $82 15 5.53
2023-09-30 $67 15 4.53
2023-06-30 $46 15 3.13
2023-03-31 $10 15 0.73

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Vanguard Emerging Markets Government Bond Etf Etf (VWOB)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Ishares S&p Global Energy Etf (IXC)
Microsoft Stock (MSFT)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Vanguard Total Stk Mkt Etf (VTI)
Exxon Mobil Corp Stock (XOM)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Spdr Gold Minishares Trust Etf (GLDM)
Avantis U.s. Equity Etf Etf (AVUS)
Spdr S&p Global Natural Resources Etf Etf (GNR)

View all positions for Versant Capital Management

Top funds holding Marker Therapeutics

NEA Management Company
Aisling Capital Management
Vanguard Group
Wedbush Morgan Securities
Dimensional Fund Advisors
Creative Planning
Matrix Asset Advisors
Advisor Group Holdings
Bank of America Corporation
Riggs Asset Managment
Us Bancorp
Wells Fargo & Company
Jpmorgan Chase & Co
Royal Bank of Canada
Versant Capital Management

View all funds holding Marker Therapeutics